CCL15 and neoplasm: Although previous studies on the CCL15-CCR1 axis have predominantly focused on tumor-derived CCL15 recruiting CCR1+ immune cells, our findings revealed that CCR1 is expressed at significantly higher basal levels in ESCC cells compared to normal esophageal epithelial HET-1A cells.